Opdivo qvantig 600 MG-10,000 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQW1E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,210
Award facts
- Contract value 100% obligated
- $72,209.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $72,209.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 10,000 units of OPDIVO (nivolumab) 600 mg in 5 mL vials. The contract, awarded on February 4, 2026, with an ultimate completion date of February 26, 2026, carries no set-aside designation and was competitively awarded. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, a major pharmaceutical distributor and subsidiary of parent company Cencora, Inc., regularly fulfills critical pharmaceutical needs for the Defense Health Agency and other federal healthcare systems through its extensive contract portfolio. OPDIVO, an immunotherapy medication used primarily for oncology applications, represents the type of specialized pharmaceutical commodities that the company supplies to military treatment facilities and government healthcare institutions. The competitive, non-set-aside nature of this award and the company's demonstrated capability to manage large-value pharmaceutical contracts underscore AmerisourceBergen's established role as a critical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQW1E?
SPE2DR26FQW1E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FQW1E worth?
The government has obligated $72,210 on SPE2DR26FQW1E.
Is contract SPE2DR26FQW1E an order under another contract?
Yes. SPE2DR26FQW1E is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQW1E competed?
The extent of competition for SPE2DR26FQW1E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award